[GAMUDA] YoY Cumulative Quarter Result on 31-Jan-2022 [#2]

Stock
[GAMUDA] GAMUDA BHD
Announcement Date
23-Mar-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2022
Quarter
31-Jan-2022 [#2]
Profit Trend
QoQ- 116.25%
YoY- 41.78%
Quarter Report
Latest QR
Upcoming QR
GAMUDA's Result
GAMUDA's Financial Summary
View:
Show?
Cumulative Result
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Revenue 6,135,450 2,749,647 2,035,447 1,659,367 2,186,543 2,029,010 1,774,580 22.95%
PBT 479,354 414,820 418,695 296,270 437,670 449,608 527,642 -1.58%
Tax -61,290 1,109,179 -66,537 -40,507 -66,184 -73,864 -85,852 -5.45%
NP 418,064 1,523,999 352,158 255,763 371,486 375,744 441,790 -0.91%
-
NP to SH 403,844 1,363,287 329,495 232,402 348,788 345,178 414,273 -0.42%
-
Tax Rate 12.79% -267.39% 15.89% 13.67% 15.12% 16.43% 16.27% -
Total Cost 5,717,386 1,225,648 1,683,289 1,403,604 1,815,057 1,653,266 1,332,790 27.45%
-
Net Worth 11,486,538 10,122,955 9,325,190 8,671,670 8,273,487 7,823,715 7,538,943 7.26%
Dividend
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Div 163,703 1,147,963 150,811 - 148,625 148,082 147,340 1.76%
Div Payout % 40.54% 84.21% 45.77% - 42.61% 42.90% 35.57% -
Equity
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Net Worth 11,486,538 10,122,955 9,325,190 8,671,670 8,273,487 7,823,715 7,538,943 7.26%
NOSH 2,734,601 2,617,909 2,513,528 2,513,527 2,481,507 2,468,050 2,456,210 1.80%
Ratio Analysis
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
NP Margin 6.81% 55.43% 17.30% 15.41% 16.99% 18.52% 24.90% -
ROE 3.52% 13.47% 3.53% 2.68% 4.22% 4.41% 5.50% -
Per Share
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
RPS 224.87 105.39 80.98 66.02 88.27 82.21 72.26 20.81%
EPS 14.92 52.56 13.11 9.25 14.09 13.99 16.88 -2.03%
DPS 6.00 44.00 6.00 0.00 6.00 6.00 6.00 0.00%
NAPS 4.21 3.88 3.71 3.45 3.34 3.17 3.07 5.40%
Adjusted Per Share Value based on latest NOSH - 2,513,528
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
RPS 217.48 97.47 72.15 58.82 77.51 71.92 62.90 22.95%
EPS 14.31 48.32 11.68 8.24 12.36 12.24 14.68 -0.42%
DPS 5.80 40.69 5.35 0.00 5.27 5.25 5.22 1.77%
NAPS 4.0716 3.5883 3.3055 3.0738 2.9327 2.7733 2.6723 7.26%
Price Multiplier on Financial Quarter End Date
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Date 31/01/24 31/01/23 31/01/22 29/01/21 31/01/20 31/01/19 30/01/18 -
Price 5.05 3.92 2.77 3.30 3.86 2.76 5.12 -
P/RPS 2.25 3.72 3.42 5.00 4.37 3.36 7.09 -17.40%
P/EPS 34.12 7.50 21.13 35.69 27.41 19.73 30.35 1.96%
EY 2.93 13.33 4.73 2.80 3.65 5.07 3.29 -1.91%
DY 1.19 11.22 2.17 0.00 1.55 2.17 1.17 0.28%
P/NAPS 1.20 1.01 0.75 0.96 1.16 0.87 1.67 -5.35%
Price Multiplier on Announcement Date
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Date 27/03/24 23/03/23 23/03/22 30/03/21 25/03/20 27/03/19 23/03/18 -
Price 5.27 4.14 3.39 3.55 2.65 2.80 5.12 -
P/RPS 2.34 3.93 4.19 5.38 3.00 3.41 7.09 -16.86%
P/EPS 35.60 7.92 25.86 38.39 18.82 20.02 30.35 2.69%
EY 2.81 12.62 3.87 2.60 5.31 4.99 3.29 -2.59%
DY 1.14 10.63 1.77 0.00 2.26 2.14 1.17 -0.43%
P/NAPS 1.25 1.07 0.91 1.03 0.79 0.88 1.67 -4.71%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment